Bill would extend tick-borne disease funding through 2030
Signed into lawS. 2398Latest action
Sponsor: Susan M. Collins · Senator · ME
AIDecoded by AI · checked against the recordRead the official text
Official title: Kay Hagan Tick Reauthorization Act
119th Congress
Topics: Health care
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
S 2398 extends federal funding for tick-borne disease research and response programs from 2025 through 2030.
40-second read · 4 questions answered below
What does this do?
This bill renews funding for federal programs combating tick-borne and other insect-spread diseases like Lyme disease, extending money for a national strategy and Regional Centers of Excellence through 2030 instead of letting it expire in 2025. It also removes a requirement to specifically consult the Tick-Borne Disease Working Group in shaping national strategy, replacing it with more general language about consulting "appropriate individuals."
Who does it affect?
Public health agencies, researchers, and state and local health departments that receive federal funding to study and respond to tick-borne diseases. Americans in regions with high rates of Lyme disease and related illnesses are indirectly affected.
Why does it matter?
Continued funding sustains disease tracking, research, and prevention programs, while the removal of the Working Group requirement changes who must be consulted in shaping national strategy.
AI-drafted summary. Check it against the official text before you act on it.
Read the official bill on Congress.govNo call to make
This is law.
Where does it stand?
- IntroducedJul 23, 2025
- Senate committee
- Senate vote
- House
- The president's desk
Right now: the president signed it. It's law.Now law
Latest action: — Became Public Law No: 119-118.